期刊名称：HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Aims and Scope
Hepatobiliary & Pancreatic Diseases International (HBPD INT) publishes peer-reviewed original papers, reviews and editorials concerned with clinical practice and research in the fields of hepatobiliary and pancreatic diseases. Papers cover the medical, surgical, radiological, pathological, biochemical, physiological and histological aspects of the subject areas under the headings Liver, Biliary, Pancreas, Transplantation, Research, Special Reports, Editorials, Review Articles, Brief Reports, Clinical Summary, New Techniques, Clinical Images and Case Reports. The journal also deals with the basic sciences and experimental work. All submitted papers are reviewed by at least two referees expert in the field of the submitted paper. For detailed instructions concerning the submission of manuscripts, please refer to the Instructions for Authors in each issue of the journal.
Disclaimer
The publisher, the hospital and the editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the publisher, the hospital or the editors, neither does the publication of advertisements constitute any endorsement by the publisher, the hospital or the editors of the products advertised.
Database
Indexed/Abstracted by
Science Citation Index Expanded (SCI-E),
Index Medicus (IM)/MEDLINE,
Chemical Abstracts (CA),
EMBASE/Excerpta Medica (EM),
ScienceDirect,
Scopus.
The latest SCI Impact Factor of Hepatobiliary & Pancreatic Diseases International is 1.259 and the 5-year Impact Factor is 1.434, according to the 2012 Journal Citation Report (JCR) released in June 2013 by Thomson Reuters.
The Impact Factor for 2011 was 1.082, according to 2011 Journal Citation Report (JCR) released in June 2012 by Thomson Reuters.
The Impact Factor for 2010 was 1.514, according to 2010 Journal Citation Report (JCR) released in June 2011 by Thomson Reuters.
The Impact Factor for 2009 was 1.183, according to 2009 Journal Citation Report (JCR) released in June 2010 by Thomson Reuters.
|
|
|
Address:
Hepatobiliary & Pancreatic Diseases International (HBPD INT),
First Affiliated Hospital,
Zhejiang University School of Medicine,
79 Qingchun Road,
Hangzhou 310003,
China.
Tel: 86-571-87236559;
86-571-87236600;
Fax: 86-571-87236600;
Email: hbpdje@gmail.com; hbpdje@zju.edu.cn
Website: http://www.hbpdint.com | |
Instructions to Authors
|
|
|
Please download the updated the "Instruction for Authors.pdf"and "Letter of Copyright Transfer.pdf" files and EndNote Output Styles file.
NOTE: Authors must read and check the Submission Guidance before submitting your manuscript.
General information
Hepatobiliary & Pancreatic Diseases International (HBPD INT) is a journal published bimonthly in English language by the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. We welcome original research articles, review articles, editorials, and others from any part of the world. Manuscripts are reviewed by members of the international editorial board and our expert peer reviewers, then either accepted for publication or rejected by the chief editor. Manuscripts should be submitted via http://mc03.manuscriptcentral.com/hbpdint.
Most of submissions accepted for publication may undergo revisions recommended by the reviewers, editors or statistical advisers. A decision takes from two weeks to three months, the longer period being due to the multiple reviews needed for articles likely to be accepted. Publication varies from two to six months after final acceptance. Proofs of edited articles and illustrations are sent to the corresponding author for correction and reply to any queries from editors. A sample copy of the journal containing the articles will be forwarded to the corresponding author within a few days of publication.
Online submissions
Original research articles including randomized trials, intervention studies, studies of screening and diagnostic tests, cohort studies, cost-effectiveness analyses and case control studies should be prepared in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (www.icmje.org). Those of randomized controlled trials (RCTs) should follow the CONSORT-statement (www.consort-statement.org). The reporting of other articles should follow the guidelines set by the different initiatives or groups listed in the appendix. The article should be submitted with two separate files, one with detailed information about authors and the title, short running title, source of the work, in addition to the names, address, telephone and fax number or email address for the corresponding author. Another file should show only the title, running title, abstract, main text, tables, figures of the submitted article as well as a list of references, which will be sent to reviewers.
The authors' names (normally no more than six) and their initials should be in the same form as in their other publications with one major qualification such as MD or PhD, their current appointment and a full postal address. One author should be named for editorial correspondence.
Each submission must be accompanied by a letter of copyright transfer signed by all the authors (see the detailed description in the last section) and other relevant documents including informed consent obtained from research subjects and research approval from the supervising or institutional ethics bodies. Author(s) of each submission should clarify the functions in or contributions to their research and declare, if any, competing interest. A choice of one of the following statements will be requested when a decision has been made to accept the paper:
1. The author or one or more of the authors have received or will receive benefits for personal or professional use from a commercial party related directly or indirectly to the subject of this article.
2. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
3. The author or authors do not choose to declare any conflict of interest related directly or indirectly to the subject of this article.
The statements selected by the author or authors will be published with the article. The signature of each author will be required. No article will be published until the completed form has been received at the Hepatobiliary & Pancreatic Diseases International office.
Manuscripts should be prepared with generous margins, and double spacing is essential throughout the text, the references and the captions. Tables, figures, captions and list of references should appear properly in the text. The style should be simple and direct, free from ambiguity and jargon, and with minimal use of abbreviations.
The title of the paper should be chosen with care: a short one has more impact and may be expanded by a subtitle.
Structured abstract of original articles should include four sections as Background, Methods, Results and Conclusions and have no more than 300 words summarizing the most important points in the article, incorporating key words suitable for electronic retrieval systems.
Background: This section should provide a precise statement of the primary focus of the study and the context in which it was carried out.
Methods: This section describes how the study was performed, including details of clinical and/or technical procedures.
Results: This section describes the salient results of the study.
Conclusions: This section covers conclusions and their clinical application or others, while equal emphasis should be given to positive and negative findings of equal scientific merit.
The main text should be divided under headings. For many research papers the best sequence is Introduction, Methods (Materials or Patients), Results, and Discussion. The text should comment on, but should not repeat, the details given in tables, figures or captions. Any acknowledgements should be made at the end of the main text.
Introduction: This should explain the problem which is to be addressed, with a definition of the hypothesis to be examined if appropriate, out-lining, briefly, its relevance to the appropriate literature.
Methods (Materials or Patients): The subjects of the study and the methods employed in the investigation must be clearly described. For example, the reasons for examining the particular group of patients should be made clear, and reasons for exclusion of individuals from the study must be stated. Any group used as controls must be defined accurately.
Ethical approval of studies and informed consent are required. For all manuscripts reporting data from studies involving human participants or animals, formal review and approval, or formal review and waiver, by an appropriate institutional review board or ethics committee is required and should be described in the Methods section. For those investigators who do not have formal ethics review committees, the principles outlined in the Declaration of Helsinki should be followed. For investigations of humans, state in the Methods section the manner in which informed consent was obtained from the study participants (i.e., oral or written). Editors may request that authors provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study.
Results: These must be clearly expressed in simple language. Tables or similar diagrams can be used but must not duplicate material already described in the text.
Discussion: This section must be succinct, pointing out the relevance of the work described in the article and its contribution to current knowledge. The results must be interpreted clearly, and both strength and weakness expressed. Discussion of pertinent references must be concise and short.
Each of the tables should have a short descriptive heading.
The references in the text should include only those that are important and have been studied fully by the authors. The authors are responsible for the accuracy and completeness of the cited references and for correct citation of the text. When listing references the names of journals should be abbreviated according to Index Medicus (List all authors and/or editors up to 6; if more than 6, list the first 6 and et al). All references will be checked deliberately by the authors; PMID roots in the abstract serial number indexed by PubMed (http://www.ncbi.nlm.nih.gov/sites/entrez?db=PubMed) are requested. The references cited should be represented in the text by superscript numbers in the order of their appearance. The list of references at the end of the text should be in this numerical order with details and punctuation as follows:
Article from journal—more than one author
Yan S, Zhang QY, Yu YS, He JJ, Wang WL, Zhang M, et al. Microsurgical reconstruction of hepatic artery in living donor liver transplantation: experiences and lessons. Hepatobiliary Pancreat Dis Int 2009;8:575-580. PMID: 20007072
Article from journals with English abstracts only
Ma Y, Hu AB, Xiong J. Migration of donor dendritic cell inducing graft acceptance in combined transplantation of liver and kidney [abstract in English]. Zhonghua Shi Yan Wai Ke Za Zhi 2006;23:750-752.
Monographic series
Davidoff RA. Migraine: manifestations, pathogenesis, and management. Philadelphia, Pa: FA Davis; 1995. Contemporary Neurology Series, No. 42.
Online journals with volume and page information
Simon JA, Hudes ES. Relationship of ascorbic acid to blood lead levels. JAMA 1999;281:2289-2293. PMID: 10386552. Accessed June 11, 2009. http://jama.ama-assn.org/cgi/content/full/281/24/2289
Online journals without volume and page information
Verschuur EM, Steyerberg EW, Tilanus HW, Polinder S, Essink-Bot ML, Tran KT, et al. Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial. Br J Cancer 2008 Dec 9. PMID: 19066612 doi: 10.1038/sj.bjc.6604811
Online website
Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5]; 1(1): [24 screens]. Available from: www.cdc.gov/ncidod/eid/vol1no1/morse.htm
Book—more than one author (list all authors if six or less, otherwise list first three followed by et al)
Baselt RC, Cravey RH. Disposition of toxic drugs and chemicals in man, 4th ed. Foster City, CA: Chemical Toxicology Institute;1995.
Chapter from a book
Calne RY. Experimental background. In: Calne RY, ed. Liver transplantation, 2nd ed. London: Grune & stratton; 1987:3-7.
Book—with editors
Maddrey WC, ed. Transplantation of the liver. New York: Elsevier Science Publishing;1998.
Illustrations Photographs, drawings, diagrams, charts and graphs should meet the editorial demands. The "three-dimensional" bar charts produced by computer programs are not acceptable. Photomicrographs with no inset scale should have the magnification of the print in the caption; stains should be indicated. The lettering on diagrams and graphs should be large enough to be clear after it has been reduced for printing and be consistent in size and style. Color will be accepted only where it is essential. Permission to reproduce any borrowed illustration must be obtained from the author and the publisher, and evidence of this permission must accompany the submitted article.
Review articles are welcome especially systematic, critical assessments of the literature and data sources pertaining to clinical topics, emphasizing factors such as cause, diagnosis, prognosis, therapy, or prevention. All articles and data sources reviewed should include information about the specific type of study or analysis, population, intervention, exposure, and tests or outcomes. All articles or data sources should be selected systematically for inclusion in the review and critically evaluated, and the selection process should be described in the article. Meta-analyses also will be considered as review articles. Editors ask potential authors of review articles to check the MOOSE initiative for meta-analysis of observational studies in epidemiology (See the appendix).
Appendix. Reporting guidelines for study designs
Study design |
|
Randomized controlled trial (RCT)--superiority design |
|
CONSORT statement |
|
(Begg C, et al. JAMA 1996;276:637-639.) |
|
|
|
RCT with non-inferiority/equivalence design |
|
Modified CONSORT statement |
|
(Piaggio G, et al. JAMA 2006;295:1152-1160.) |
|
|
|
Systematic review of therapeutic interventions |
|
QUOROM statement |
|
(Moher D, et al. Lancet 1999;354:1896-1900.) |
|
|
|
Diagnostic test performance study |
|
STARD statement |
|
(Bossuyt PM, et al. Clin Chem 2003;49:1-6.) |
|
|
|
Systematic review of diagnostic tests |
|
QUADAS statement |
|
(BMC Med Res Method 2006;6(9). doi: 10.1186/1471-2288-6-9.) |
|
|
|
Systematic review of observational study |
|
MOOSE statement |
|
(Stroup DF, et al. JAMA 2000;283:2008-2012.) |
|
|
|
Economic evaluations |
|
(Evers S, et al. Int J Tech Assess Health Care 2005;21:240-245.) |
|
|
Brief report is to report novel research findings that might stimulate further research or alert readers to clinically relevant but preliminary information. A brief report should have no more than 1500 words, a maximum of ten references, and two tables or figures. An unstructured summary of no more than 200 words is required to include background, methods, findings, and interpretation.
The articles in the departments Clinical summary, New techniques focus on the clinical treatment of diseases or new techniques used, which are of interest to clinicians and researchers.
Case reports should describe a rare case but a surgeon or physician might encounter, in which there was some difficulty in reaching a diagnosis, and that provides a teaching point. Preferably the case should have a good illustration. Consent for publication must be obtained from the patient.
Clinical images, clear and interesting, are submitted with a descriptive paragraph of 500-1000 words. Authors must obtain signed informed consent from the patient.
Letters to the editor on matters of recently published articles in the journal are especially welcome. Letters should be received after publication of the article and should not exceed 400 words and 5 references.
Notes, news or announcements for conferences, symposia or meetings may be sent for publication at least 3 months before the required date of publication. These are mostly included under Meetings and Courses without payment. Provide title, date(s) and place of the event and contact address, telephone, and email address. Hepatobiliary & Pancreatic Diseases International reserves the right to be selective in publishing these announcements. Those wishing for a detailed publication may submit as advertisements. For academic information, subsidized rates are available.
Letter of copyright transfer
We require a letter of copyright transfer signed by all named authors, stating that they have taken a significant and active part in the preparation of the article, that they have read and approved the final version, and are willing to discuss it in detail. This is essential for the reviewing process to be completed. Possibly duplicative materials (i.e., those containing substantially similar content or using the same or similar data) that have been previously published or are being considered elsewhere must be provided at the time of manuscript submission.
To conform with the Copyright Act of China, this letter must contain the following paragraph:
In consideration of Hepatobiliary & Pancreatic Diseases International reviewing and editing my (our) submission, the author(s) undersigned hereby transfer(s), assign(s), or otherwise conveys all copyright ownership to Hepatobiliary & Pancreatic Diseases International represent(s) that he (they) own(s) all rights in the material submitted. The author(s) further confirm(s) that the article is original, that it is not under consideration by another journal in any language, and that it has not been previously published, in whole or in part, in another journal in any language. There is no conflict of interests relevant to the study reported in this article.
For convenience potential author can download the form of the letter from our journal's website. This assignment is to take effect only if the work is accepted for publication in Hepatobiliary & Pancreatic Diseases International.
These instructions can also be found on the journal's website at www.hbpdint.com and may be copied by those intending to submit an article. | |
Instructions to Authors
Instructionfor Authors.pdf
Editorial Board
|
|
|
.JPG)
Shu-Sen Zheng, professor of surgery and president of the First Affiliated Hospital, Zhejiang University School of Medicine, was born in Zhejiang Province, China in January 1950. He finished his undergraduate study at the Department of Medicine, Zhejiang Medical University, Hangzhou in 1973 and obtained a master degree in 1986. He received a doctoral degree at the Department of Hepatobiliary Surgery, West China University of Medical Sciences, Chengdu in 1989. Subsequently, he pursued his 2-year post-doctoral study at the Department of Surgery, the Queen Mary Hospital, Hong Kong. He became a doctoral tutor in 1998 and was elected as a member of the Chinese Academy of Engineering in 2001. Professor Zheng has contributed greatly to the progress of general surgery at the First Affiliated Hospital, Zhejiang University School of Medicine since his return from Hong Kong in 1992. He initiated the training program for organ transplantation at the hospital the same year and carried out orthotopic liver transplantation in 1993, combined pancreas-kidney trans-plantation in 1994, combined liver-kidney transplantation in 1999, and living-related liver transplantation in 2001. To the present, a total of 1063 patients have undergone liver transplantation successfully at his hospital with a 1-year survival rate of 95.2% for patients with end-stage liver diseases. Prof. Zheng performed the combined pancreas-kidney transplantation in 1994 and the combined liver-kidney transplantation in 1999, and 2 recipients holds the longest post combined pancreas-kidney transplantation survival record in Asia (17 years) and the longest post combined liver-kidney transplantation survival record in the mainland of China (12 years).
Professor Zheng is active in basic and clinical research, especially in immunology of organ transplantation, graft injury and preservation. At present, he is responsible for two national projects and eight provincial projects in his specialties. He is a winner of two national science awards and five provincial prizes for science and technology advancement. As a tutor of post doctors, doctors, and postgraduates, he published over 400 papers in core medical journals national or international and several monographs such as Liver Transplantation, Pancreas Transplantation, Management in Peri-operative Period of Liver Transplantation, etc. He holds many governmental or organizational positions, including Chairman of the Chinese Medical Association of Organ Transplant, member of the Life Science Committee, Ministry of Education and director of Key Laboratory of Multi-Organ Transplantation, Ministry of Health, China, and Fellow of the American College of Surgeons.
|
|
|
Honorary chief editor
Zhao-You Tang, Shanghai
Chief editor
Shu-Sen Zheng, Hangzhou
Deputy chief editors
Sheung Tat Fan, Hong Kong
Xi-Sheng Leng, Beijing
Lu-Nan Yan, Chengdu
Advisers
Zhi-Qiang Huang, Beijing
Jie-Shou Li, Nanjing
Meng-Chao Wu, Shanghai
Managing editor
Shou-Chu Qian, Beijing
Deputy managing editors
Cong Zhu, Hangzhou
Yan-Ping Dong, Hangzhou
Editors
Shui-Ying Lei, Hangzhou
Pan-Zhi Wang, Hangzhou
Di-Fei Bian, Hangzhou
, Hangzhou
Desktop technician
Chen-Hua Xiong, Hangzhou
International editorial board (PDF)
| H. Erdal Akalin, Istanbul |
Hao-Feng Ji, Los Angeles |
Lawrie W. Powell, Brisbane |
| Moulay A. Alaoui-Jamali, Montreal |
Ji-Dong Jia, Beijing |
Satya Prakash, Montreal |
| Åke Andrén-Sandberg, Stockholm |
Zhen-Dong Jin, Shanghai |
Sasan Roayaie, New York |
| Ignacio Anegon, Nantes |
Hong-En Jing, Xining |
Thomas Rösch, Berlin |
| Peter Bannasch, Heidelberg |
Colin Johnson, Southampton |
Shiv K. Sarin, New Delhi |
| Richard Bertrand, Montreal |
Robert M. Jones, Melbourne |
Detlef Schuppan, Boston |
| Henri Bismuth, Villejuif |
Holger Kalthoff, Kiel |
Yong-Fu Shao, Beijing |
| Hubert E. Blum, Freiburg |
Mitsuhiro Kida, Kanagawa |
Ji-Fang Sheng, Hangzhou |
| James L. Boyer, New Haven |
Tetsuya Kiuchi, Kyoto |
Bing-Yi Shi, Beijing |
| Heinz J. Buhr, Berlin |
Sebastian Klammt, Rostock |
Yu-Ling Sun, Zhengzhou |
| Ronald W. Busuttil, Los Angeles |
Andrew S. Klein, Baltimore |
Joseph J.Y. Sung, Hong Kong |
| Hui Cao, Shanghai |
Bernd Kremer, Kiel |
Kyuichi Tanikawa, Kurume |
| See-Ching Chan, Hong Kong |
Jerzy W. Kupiec-Weglinski, Los Angeles |
Ran Tao, Shanghai |
| Chao-Long Chen, Kaohsiung |
Cheuck-Seen Lai, Hong Kong |
Catherine Teh, Manila |
| Gui-Hua Chen, Guangzhou |
John R. Lake, Minneapolis |
Li-Song Teng, Hangzhou |
| Shi Chen, Wuhan |
Wan-Yee Lau, Hong Kong |
Pierre Tiollais, Paris |
| Xiao-Ping Chen, Wuhan |
Sung-Gyu Lee, Seoul |
D. Lorne Tyrrell, Edmonton |
| Ya-Gang Chen, Hangzhou |
Gary Levy, Toronto |
William J. Wall, London |
| Zhi Chen, Hangzhou |
Bo Li, Chengdu |
Bao-En Wang, Beijing |
| Zhong-Hua Chen, Wuhan |
Lan-Juan Li, Hangzhou |
Bao-Zhong Wang, Melbourne |
| Jun Cheng, Beijing |
Li Li, Kunming |
Chun-You Wang, Wuhan |
| Yu-Fan Cheng, Kaohsiung |
Ning Li, Beijing |
Wei-Lin Wang, Hangzhou |
| Yung-Chi Cheng, New Haven |
Ning Li, Nanjing |
Xue-Hao Wang, Nanjing |
| Sheung-Chee Chung, Hong Kong |
Shi-Yong Li, Beijing |
Yu-Ming Wang, Chongqing |
| Maria Cristina Cuturi, Nantes |
You-Ming Li, Hangzhou |
Lai Wei, Beijing |
| Francis L. Delmonico, Boston |
You-Sheng Li, Nanjing |
Hao Wen, Urumqi |
| Christos Dervenis, Athens |
Yu-Min Li, Lanzhou |
Roger Williams, London |
| Yi-Tao Ding, Nanjing |
Zhao-Shen Li, Shanghai |
Jian Wu, Hangzhou |
| Jia-Hong Dong, Beijing |
Ting-Bo Liang, Hangzhou |
Nan-Ping Wu, Hangzhou |
| Ke-Feng Dou, Xi'an |
En-Qiang Linghu, Beijing |
Youmin Wu, Valhalla |
| Mohamed El-Wahsh, Cairo |
Hongqun Liu, Calgary |
Zhi-Yong Wu, Shanghai |
| Weimin Fan, Charleston |
Ke-Zhou Liu, Hangzhou |
Zhong-Jun Wu, Chongqing |
| Peter Ferenci, Wien |
Yong-Feng Liu, Shenyang |
Xiao Xu, Hangzhou |
| John J. Fung, Cleveland |
Yu-Lan Liu, Beijing |
Sheng Yan, Hangzhou |
| Tiejun Gao, Edmonton |
Alan S. Livingstone, Miami |
Dong-Liang Yang, Wuhan |
| Edward K. Geissler, Regensburg |
Chung-Mau Lo, Hong Kong |
Jia-Mei Yang, Shanghai |
| Stephanos Geroulanos, Athens |
Yi Lv, Xi'an |
Lian-Yue Yang, Changsha |
| Biao Gong, Shanghai |
Nicolaos J. Lygidakis, Athens |
Kenjiro Yasuda, Kyoto |
| Fei-Li Gong, Wuhan |
Willis C. Maddrey, Dallas |
Qi-Fa Ye, Changsha |
| Gail Ter Haar, Sutton |
Larry McNicol, Melbourne |
Wai Key Yuen, Hong Kong |
| Xiao-Shun He, Guangzhou |
Ying-Zi Ming, Changsha |
Yuan Zhai, Los Angeles |
| Nigel D. Heaton, London |
Peter Neuhaus, Berlin |
Yu-Pei Zhao, Beijing |
| Matthias W. Hoffmann, Münster |
Qin Ning, Wuhan |
Jie Zhong, Shanghai |
| F. Blaine Hollinger, Houston |
Jun-Qi Niu, Jilin |
Ning-Xin Zhou, Beijing |
| Hubert G. Hotz, Berlin |
Isto Nordback, Tampare |
Ji-Ye Zhu, Beijing |
| Dong-Sheng Huang, Hangzhou |
Gerd Otto, Mainz |
Yue Zhu, Pittsburgh |
| Yukio Ichikawa, Yokohama |
Massimo Pinzani, Firenze |
Sheng-Quan Zou, Wuhan | | | | |
|
